Susan Molineaux

Slammed with PhII flop for lead drug, Calithera lays off a third of its staffers

Calithera Bio­sciences will be go­ing in­to the new year with on­ly two-thirds of its staff.

The South San Fran­cis­co-based biotech is lay­ing off “around 30 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.